Logo image of WOK

WORK MEDICAL TECHNOLOGY GROU (WOK) Stock Fundamental Analysis

NASDAQ:WOK - Nasdaq - KYG9767H1092 - Common Stock - Currency: USD

0.6352  -0.08 (-11.78%)

After market: 0.621 -0.01 (-2.24%)

Fundamental Rating

2

Overall WOK gets a fundamental rating of 2 out of 10. We evaluated WOK against 188 industry peers in the Health Care Equipment & Supplies industry. While WOK is still in line with the averages on profitability rating, there are concerns on its financial health. WOK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

WOK had positive earnings in the past year.
WOK had a positive operating cash flow in the past year.
WOK Yearly Net Income VS EBIT VS OCF VS FCFWOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M -4M -6M

1.2 Ratios

With a decent Return On Assets value of 0.37%, WOK is doing good in the industry, outperforming 71.51% of the companies in the same industry.
WOK has a Return On Equity of 1.13%. This is in the better half of the industry: WOK outperforms 73.12% of its industry peers.
The Return On Invested Capital of WOK (1.47%) is better than 68.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for WOK is in line with the industry average of 7.84%.
The 3 year average ROIC (6.50%) for WOK is well above the current ROIC(1.47%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.37%
ROE 1.13%
ROIC 1.47%
ROA(3y)7.73%
ROA(5y)N/A
ROE(3y)23.04%
ROE(5y)N/A
ROIC(3y)6.5%
ROIC(5y)N/A
WOK Yearly ROA, ROE, ROICWOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 10 20 30 40 50

1.3 Margins

WOK has a Profit Margin of 0.83%. This is in the better half of the industry: WOK outperforms 72.04% of its industry peers.
WOK has a Operating Margin of 3.04%. This is in the better half of the industry: WOK outperforms 68.82% of its industry peers.
WOK's Gross Margin of 30.54% is on the low side compared to the rest of the industry. WOK is outperformed by 75.81% of its industry peers.
Industry RankSector Rank
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WOK Yearly Profit, Operating, Gross MarginsWOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WOK is destroying value.
Compared to 1 year ago, WOK has about the same amount of shares outstanding.
The debt/assets ratio for WOK is higher compared to a year ago.
WOK Yearly Shares OutstandingWOK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M
WOK Yearly Total Debt VS Total AssetsWOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M

2.2 Solvency

WOK has an Altman-Z score of 1.43. This is a bad value and indicates that WOK is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.43, WOK perfoms like the industry average, outperforming 56.45% of the companies in the same industry.
WOK has a debt to FCF ratio of 5.44. This is a neutral value as WOK would need 5.44 years to pay back of all of its debts.
WOK has a better Debt to FCF ratio (5.44) than 77.96% of its industry peers.
WOK has a Debt/Equity ratio of 0.90. This is a neutral value indicating WOK is somewhat dependend on debt financing.
The Debt to Equity ratio of WOK (0.90) is worse than 76.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 5.44
Altman-Z 1.43
ROIC/WACC0.22
WACC6.8%
WOK Yearly LT Debt VS Equity VS FCFWOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 1.17 indicates that WOK should not have too much problems paying its short term obligations.
The Current ratio of WOK (1.17) is worse than 86.56% of its industry peers.
WOK has a Quick Ratio of 1.17. This is a bad value and indicates that WOK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of WOK (0.93) is worse than 82.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.93
WOK Yearly Current Assets VS Current LiabilitesWOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for WOK have decreased strongly by -87.10% in the last year.
WOK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.18%.
EPS 1Y (TTM)-87.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.96%
Revenue 1Y (TTM)-31.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-63.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOK Yearly Revenue VS EstimatesWOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 10M 20M 30M 40M
WOK Yearly EPS VS EstimatesWOK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

WOK is valuated quite expensively with a Price/Earnings ratio of 63.52.
WOK's Price/Earnings ratio is a bit cheaper when compared to the industry. WOK is cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.75, WOK is valued quite expensively.
Industry RankSector Rank
PE 63.52
Fwd PE N/A
WOK Price Earnings VS Forward Price EarningsWOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WOK indicates a rather cheap valuation: WOK is cheaper than 98.39% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WOK indicates a rather cheap valuation: WOK is cheaper than 99.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.7
EV/EBITDA 4.42
WOK Per share dataWOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WOK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WORK MEDICAL TECHNOLOGY GROU

NASDAQ:WOK (3/3/2025, 8:02:28 PM)

After market: 0.621 -0.01 (-2.24%)

0.6352

-0.08 (-11.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.83%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.27M
AnalystsN/A
Price TargetN/A
Short Float %1.14%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 63.52
Fwd PE N/A
P/S 0.68
P/FCF 5.7
P/OCF 4.19
P/B 0.94
P/tB 1.04
EV/EBITDA 4.42
EPS(TTM)0.01
EY1.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY17.55%
OCF(TTM)0.15
OCFY23.84%
SpS0.93
BVpS0.68
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.37%
ROE 1.13%
ROCE 3.74%
ROIC 1.47%
ROICexc 1.6%
ROICexgc 1.7%
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
FCFM 11.99%
ROA(3y)7.73%
ROA(5y)N/A
ROE(3y)23.04%
ROE(5y)N/A
ROIC(3y)6.5%
ROIC(5y)N/A
ROICexc(3y)6.72%
ROICexc(5y)N/A
ROICexgc(3y)7.14%
ROICexgc(5y)N/A
ROCE(3y)14.39%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 5.44
Debt/EBITDA 4.39
Cap/Depr 36.39%
Cap/Sales 4.3%
Interest Coverage 1.32
Cash Conversion 109.65%
Profit Quality 1452.14%
Current Ratio 1.17
Quick Ratio 0.93
Altman-Z 1.43
F-Score6
WACC6.8%
ROIC/WACC0.22
Cap/Depr(3y)33.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-63.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y138.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y197.82%
OCF growth 3YN/A
OCF growth 5YN/A